Quick Answer
Annovis Bio, Inc. reported Total Assets of $21.08 million for fiscal year 2025.
Annovis Bio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $21.08M | +51.4% |
| 2024 | $13.93M | +36.4% |
| 2023 | $10.21M | -71.7% |
| 2022 | $36.02M | -3.0% |
| 2022 | $37.12M | -7.1% |
| 2022 | $39.97M | -9.4% |
| 2022 | $44.10M | -4.1% |
| 2021 | $46.00M | +466.6% |
| 2020 | $8.12M | +626.8% |
| 2019 | $1.12M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $17.19M | +19.7% | -19.9% |
| June 30, 2025 | $21.45M | +325.1% | -19.8% |
| March 31, 2025 | $26.74M | +242.2% | +92.0% |
| December 31, 2024 | $13.93M | +36.4% | -3.0% |
| September 30, 2024 | $14.36M | +40.5% | +184.6% |
| June 30, 2024 | $5.05M | -77.9% | -35.4% |
| March 31, 2024 | $7.81M | -69.4% | -23.5% |
| December 31, 2023 | $10.21M | -71.7% | -0.1% |
- Annovis Bio, Inc. showed an increase of +51.4% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Annovis Bio, Inc.’s total assets has grown by 1787.2% (from $1.12 million to $21.08 million).
- The most recent figure is from Annovis Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: